Neither route is backed by human clinical trial data, so any route advantage is extrapolated from animal pharmacology
Additional Monitoring May Be Considered In: Higher-frequency regenerative research protocols Long-duration experimental protocols Multiple concurrent regenerative or metabolic-support compounds Significant peptide-sensitivity research models Liver-function or copper-metabolism-related investigations due to the inclusion of GHK-Cu Avoid or Carefully Evaluate In Research Models With: Known hypersensitivity to peptide compounds Active severe systemic illness Severe uncontrolled cardiovascular, metabolic, or neurological conditions Active or suspected malignancy-related, tumor-related, or abnormal proliferative conditions Pregnancy or breastfeeding contexts Additional Research Considerations Because Glow Blend contains GHK-Cu, prolonged or higher-frequency research exposure may influence copper and zinc balance in some research settings

Copper toxicity can lead to multi-organ failure, neurologic impairment, and even death (13) Differences in product quality and regulation Experts, including the FDA, have not approved GHK-Cu for many uses and people should only use investigational oral or injectable GHK-Cu under medical supervision
Its essential to set realistic expectations: individual outcomes may vary based on factors such as skin type, hair condition, and the specific formulation used